Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 16 Uterine Cervical Dysplasia 13 Precancerous Conditions 3 Squamous Intraepithelial Lesions 2 Papillomavirus Infections 2 Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Diseases 1 HIV Infections 1 Cervical Intraepithelial Neoplasia Grade 1 (CIN 1) 1 Adenocarcinoma in Situ 1 Acquired Immunodeficiency Syndrome 1

Interventions

Cyclophosphamide 3 fludarabine phosphate 2 Whole-Body Irradiation 2 Vincristine 2 Vaccines 2 Rituximab 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Papillomavirus Vaccines 2 Mass Screening 2 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2 Etoposide 2 Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 2 pandemrix 1 lactitol 1 halofantrine 1 focetria 1 fludarabine 1 efineptakin alfa 1 efavirenz 1 X-Rays 1 VAP-cyclo protocol 1 Triage 1 Transplantation Conditioning 1 Tomography, X-Ray Computed 1 Thiotepa 1 Therapeutics 1 Surveys and Questionnaires 1 Standard of Care 1 Spirometry 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × HIV Infections × Colposcopy × Clear all

NCT05074264 2025-11-10

CAMPO-101

University of California, San Francisco

Phase NA Active not recruiting

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡